CBO: Biogenerics Would Save Federal Government $6.6 Billion Over... ( Creation of Clear Regulatory Path...)

CBO: Biogenerics Would Save Federal Government $6.6 Billion Over Ten Years

Date:6/25/2008

Creation of Clear Regulatory Pathway Would Also Lower Total Expenditures for Biologics by $25 Billion Over Ten Years

WASHINGTON, June 25 /PRNewswire-USNewswire/ -- The Congressional Budget Office (CBO) today released a cost analysis finding that the creation of an abbreviated pathway for follow-on biologics -- or biogenerics -- would save the federal government $6.6 billion over ten years and lower total expenditures for biologics by $25 billion over the same time period.

"For a quarter century, generic versions of chemical drugs have saved consumers and payors billions of dollars. Now, CBO has confirmed that giving FDA additional authority to approve generic versions of biologics will save billions more," said PCMA President and CEO Mark Merritt. "Even greater savings would be available if Congress simply applied to biologics the Hatch-Waxman standards that are currently used to approve generics for chemical compounds. It would be helpful if some provisions in the bill -- such as 'evergreening' -- which unnecessarily delay the entry of biogenerics were reconsidered. CBO acknowledges that the 'evergreening' issue will present significant problems beyond the ten-year scoring window."

CBO estimates that:

-- Enacting S. 1695 would reduce total expenditures on biologics in the

United States Hidden List by $25 billion over the 2009-2018

period.

-- Enacting the bill would reduce budget deficits (or increase surpluses)

by a total of $6.6 billion over the 2009-2018 period.

Unlike conventional drugs, there is no clear regulatory process where biogenerics can be approved by the FDA. PCMA was joined by a number of influential consumer, employer, and insurer groups who endorsed the "Access to Life Saving Medicine Act of 2007," bipartisan legislation that seeks to create a clear regulatory pathway for biogenerics.

PCMA is the national association representing Americ
'/>"/>

SOURCE Pharmaceutical Care Management Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
2. Biogenerics Will Save Billions, Says Hospira CEO
3. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
4. Coalition for a Competitive Pharmaceutical Market Launches New Print Ad Campaign Highlighting Need for Meaningful Biogenerics Legislation
5. Op-Ed: The NBAF Would Build on Kansas Existing Strengths in Bioscience
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
8. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
9. Zimmer Announces Settlement of Federal Investigation
10. DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program
11. Federally-Funded Study Shows More Women Can Avoid Hysterectomy for Common Problem

Post Your Comments:

(Date:2/8/2010)... the ClearTrial clinical services team to present the critical processes ... clinical development departments. , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced that both ... have been selected to speak at the CBI Forecasting & ...

(Date:2/6/2010)... University Belfast are developing new sensors to detect chemical ... fight against the threat of terrorist attacks. , The ... individual or crime scene to gather a sample which ... detect the presence of chemicals within seconds. This will ... to terrorist threats. , The scanning instrument will ...

(Date:2/5/2010)... Valencia (UV) has confirmed that the substance used to ... in Morocco, was pine resin. The scientists also studied ... be fragments of material used for iron-working. , In ... a sealed amphora among the remains at Lixus, an ... Morocco. Since then, researchers from the Department of Analytical ...

(Date:2/5/2010)... , Feb. 5 Amicus Therapeutics ... of Directors has elected John F. Crowley ... current role as Chief Executive Officer (CEO), effective immediately. ... , who will become the Lead Independent Director of ... Crowley as Chairman of the Board reflects our confidence ...

Breaking Biology Technology:ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 2 ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 3 ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 4 New technology detects chemical weapons in seconds 2 Chemical analyses uncover secrets of an ancient amphora 2 Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board 2

[0] ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference [0] New technology detects chemical weapons in seconds [0] Chemical analyses uncover secrets of an ancient amphora [0] Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board

... Seventh Study Showing Oncotype DX Frequently Changes Treatment ... Recommendations in Clinical Practice -, ... GHDX ) today announced the publication of results from a ... treat early-stage breast cancer. The study, published in the,October issue ...

... Presented at the Meeting Report the Use of ... Tight Glycemic Control in,Diabetics, MONTVALE, N.J., Nov. ... today announced at the Annual Scientific,Sessions of the ... a,new clinical test to determine haptoglobin (Hp) genotype ...

... WaferGen Biosystems,Inc. (OTC Bulletin Board: WGBS), a leading developer ... research systems,today highlighted the company,s recent developments and announced ... 30, 2008., Recent Corporate Developments: -- ... awarded a team of researchers ...

Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association WaferGen Announces Third Quarter 2008 Financial Results

(Date:2/8/2010)... offers a wealth of data about how cells respond ... systems is a daunting challenge. In a study ... ), researchers have developed a novel method of interpreting ... biological networks, offering a glimpse into the future of ... been peering through a microscope at cells as they ...

(Date:2/8/2010)... -- With the recent election of Senator Scott ... loss of the Democratic supermajority, the urgency behind broad-based ... for the majority of uninsured Americans has faded dramatically, ... recently noted the country is closer than it has ... a long sought after social reform, and the President ...

(Date:2/8/2010)... cancer is the most common cancer of the female ... is currently no screening method or biomarker to indicate ... malignancy that affects women of all ages" comments paper ... the cells that grow along the inner lining of ... it is diagnosed following patient reports of abnormal bleeding. ...

[0] Method of the future uses single-cell imaging to identify gene interactions [0] S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now?[0] A potent suppressor of endometrial cancer is revealed

... climate change, Cornell University entomologists show that the social behavior ... period of global warming. , This social evolution occurred ... million to 22 million years ago, compared with the social ... years ago. , "We believe that climatic change was a ...

... new bacterium in an immune-compromised patient, according to a ... belongs to the family Acetobacteraceae and includes bacteria common ... industry, such as vinegar-making. "This is the first ... of the Acetobacteraceae," according to the article. ...

... A new, more robust analysis of recently derived human ... University in St Louis, shows three distinct major waves ... two, and statistically refutes –strongly ?the 'Out of ... of Homo sapiens left Africa 100,000 years ago and ...

Other Biology News:Sociality of sweat bees evolved simultaneously during climate change 2 Scientists discover a new disease-causing bacterium in an immune-compromised patient 2 New analysis shows three human migrations out of Africa 2

Sociality of sweat bees evolved simultaneously during climate change Scientists discover a new disease-causing bacterium in an immune-compromised patient New analysis shows three human migrations out of Africa

The Bio-Plex Manager version 3.0 to 4.0 workstation software upgrade kit is used to upgrade existing Bio-Plex Manager version 3.0 software to version 4.0 security edition software....

... siRNA --- a cocktail of 3 siRNAs ... interestis our most popular product. The siTrio ... knockdown of your target gene when used ... transfection and confirmation of optimal transfection with ...

... offers a large collection of phage ... tissuea, cell lines, and mouse tissues. ... pHD9 vector. The size of cDNA ... from 200bp to 1000bp by gel ...

... This kit #27295 has improved stability and convenience ... kit not only has overcome this problem but ... we have changed the formulation of HRP conjugated ... 1). By this change, the stability of the ...

Biology Products:

Bio-Plex Manager Version 3.0 to 4.0 Workstation Software Upgrade Kit from Bio-Rad Rat siTrio from B-Bridge International Phage Display cDNA Library Screening Kit from Spring Bioscience Rat Leptin Assay Kit from Immuno-Biological Laboratories, Inc.

CBO: Biogenerics Would Save Federal Government $6.6 Billion Over...( Creation of Clear Regulatory Path...)